Rahul K. Chaliparambil

Also affiliated with Neurological Surgery, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas”.

Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas

JCI Insight(2025)10.1172/jci.insight.195385

N/A

0.104DataRank · unranked

1 citations

Matthew McCord, Wenxia Wang, Alicia Steffens, Kathleen McCortney, Rahul K. Chaliparambil +3 more

Considering the Role of Information and Context in Promoting Health‐Related Behavioral Change

Proceedings of the Association for Information Science and Technology(2023)10.1002/pra2.894

N/A

0DataRank · unranked

0 citations

Shana Johnny, Rahul K. Chaliparambil, Sharon Wong, Joseph E. Glass, Annie Chen

The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma

Neuro-Oncology(2024)10.1093/neuonc/noae257

N/A

0DataRank · unranked

9 citations

Thomas Sears, Wenxia Wang, Rahul K. Chaliparambil, Shejuan An, Jann N. Sarkaria +6 more